A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

NCT05233657 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: JX11502MA
DRUG: Placebo

Sponsor

Zhejiang Jingxin Pharmaceutical Co., Ltd.